AHCO - NASDAQ
AdaptHealth Corp.
$9.72
+0.73%AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
At a Glance
Live SnapshotAdaptHealth Corp. Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Non-operating losses: Core business is profitable but other expenses (interest, taxes, one-time items) are driving net losses. Review capital structure and non-operating items.
AdaptHealth Corp. Income Statement
AHCO • NASDAQ
| AdaptHealth Corp. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||
3.2B | 3.3B | 3.2B | 3B | 2.5B | 1.1B | 529.6M | 345.3M | 192.6M | 174.3M | |
GROSS PROFIT | ||||||||||
(2.7B) | (2.6B) | (2.5B) | (2.6B) | (2B) | (898.6M) | (440.7M) | (285.2M) | (162.9M) | (158.7M) | |
568.6M | 681.1M | 681.8M | 417.4M | 445.6M | 157.8M | 88.9M | 60.1M | 29.7M | 15.6M | |
OPERATING INCOME | ||||||||||
(382.3M) | (417.4M) | (1.3B) | (227M) | (220M) | (86.4M) | (59.6M) | (1.2M) | (693.0) | (13.3M) | |
(382.3M) | (359.2M) | (190.1M) | (162.1M) | (167.5M) | (89.3M) | (56.5M) | (1M) | (693.0) | (11.4M) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (310K) | (0.0) | |
186.3M | 263.7M | -598.4M | 190.4M | 225.6M | 71.3M | 29.4M | -1.2M | -690.0 | 2.3M | |
PRE-TAX INCOME | ||||||||||
(105.8M) | (126.7M) | (130.3M) | (109.4M) | (95.2M) | (41.4M) | (39.3M) | (4.1M) | (0.0) | (0.0) | |
-105.8M | -126.7M | -130.3M | -109.4M | -95.2M | -41.4M | -39.3M | 0.0 | 0.0 | 0.0 | |
(0.0) | (58.1M) | (1.1B) | (64.9M) | (52.5M) | -2.9M | (3.1M) | (197.6K) | (0.0) | (0.0) | |
-201.4M | -127.7M | -125.4M | -92.5M | -34.6M | -277.4M | -51.2M | -8.9M | 0.0 | -5.8M | |
-15.2M | 136M | -723.8M | 97.9M | 191M | -206M | -21.9M | 2.9M | -693.0 | -3.4M | |
NET INCOME | ||||||||||
(50.9M) | (41.2M) | -49M | (24.8M) | (32.8M) | -12M | (739K) | (829.8K) | (0.0) | -208.4K | |
-70.8M | 90.4M | -678.9M | 69.3M | 156.2M | -161.6M | -21.3M | 2.1M | -693.0 | -3.8M |
SEC Filings
AHCO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K/A 8-K/A 2026 (Amended) N/A | June 02, 2026 | May 04, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 10, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 04, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 05, 2025 | June 30, 2025 | 2025 |
Related Guides
Continue your AHCO research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.